SCHEMBL17554100

SCHEMBL17554100

O=C(Nc1ccccc1C(=O)NCCN1CCOCC1)c1cccc(Cl)c1

nearest known ligand 0.75

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
HTT P42858 1/20 0.75
BCL3 P20749 6/20 0.71
POLB P06746 2/20 0.69
ALDH1A1 P00352 4/20 0.66
GAA P10253 1/20 0.66
KMT2A Q03164 2/20 0.62
MEN1 O00255 1/20 0.62
CYP1A2 P05177 1/20 0.62
CYP3A4 P08684 1/20 0.62
CYP2D6 P10635 1/20 0.62
CYP2C9 P11712 1/20 0.62
CYP2C19 P33261 1/20 0.62
EPHX2 P34913 2/20 0.59
HTR1A P08908 1/20 0.56
MAOA P21397 1/20 0.56
MAOB P27338 1/20 0.56
KCNH2 Q12809 1/20 0.56
CD274 Q9NZQ7 1/20 0.56

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL17554054 0.89 POLB (0.60) HTTBCL3POLBALDH1A1GAA
SCHEMBL17554058 0.89 HTT (0.59) HTTBCL3POLBALDH1A1GAA
SCHEMBL17554174 0.89 BCL3 (0.76) HTTBCL3POLBALDH1A1GAA
SCHEMBL29849958 0.88 POLB (0.87) HTTBCL3POLBALDH1A1GAA
SCHEMBL16430973 0.88 POLB (0.87) HTTBCL3POLBALDH1A1GAA
SCHEMBL23412997 0.88 BCL3 (0.71) HTTBCL3POLBALDH1A1GAA
SCHEMBL30092923 0.88 BCL3 (0.71) HTTBCL3POLBALDH1A1GAA
SCHEMBL16431055 0.88 BCL3 (0.85) HTTBCL3POLBALDH1A1GAA
SCHEMBL29849769 0.88 BCL3 (0.85) HTTBCL3POLBALDH1A1GAA
SCHEMBL17554135 0.88 BCL3 (0.71) HTTBCL3POLBALDH1A1GAA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 12 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3628374-B1 BCL-3 INHIBITORS UNIV COLLEGE CARDIFF CONSULTANTS LTD (GB) 2023-08-30 EP disclosed
EP-3628374-B1 BCL-3 INHIBITORS UNIV COLLEGE CARDIFF CONSULTANTS LTD (GB) 2023-08-30 EP disclosed
EP-3628374-A2 BCL-3 INHIBITORS University College Cardiff Consultants Limited (GB) 2020-04-01 EP disclosed
EP-3628374-A2 BCL-3 INHIBITORS University College Cardiff Consultants Limited (GB) 2020-04-01 EP disclosed
US-20190248756-A1 BCL-3 INHIBITORS UNIV COLLEGE CARDIFF CONSULTANTS LTD (GB) 2019-08-15 US disclosed
US-20190248756-A1 BCL-3 INHIBITORS UNIV COLLEGE CARDIFF CONSULTANTS LTD (GB) 2019-08-15 US disclosed
US-10273218-B2 BCL-3 inhibitors UNIVERSITY COLLEGE CARDIFF CONSULTANTS LIMITED (GB) 2019-04-30 US disclosed
US-10273218-B2 BCL-3 inhibitors UNIVERSITY COLLEGE CARDIFF CONSULTANTS LIMITED (GB) 2019-04-30 US disclosed
US-20170267653-A1 BCL-3 INHIBITORS UNIVERSITY COLLEGE CARDIFF CONSULTANTS LIMITED (GB) 2017-09-21 US disclosed
US-20170267653-A1 BCL-3 INHIBITORS UNIVERSITY COLLEGE CARDIFF CONSULTANTS LIMITED (GB) 2017-09-21 US disclosed
EP-3174602-A2 BCL-3 INHIBITORS University College Cardiff Consultants Limited (GB) 2017-06-07 EP disclosed
WO-2016016728-A2 BCL-3 INHIBITORS UNIVERSITY COLLEGE CARDIFF CONSULTANTS LIMITED (GB) 2016-02-04 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20190248756-A1 BCL-3 INHIBITORS BCL3, BCL2, BCL2L13 HTT 3212/4885BCL3 1/4885POLB 1797/4885
US-10273218-B2 BCL-3 inhibitors BCL3, BCL2, BCL2L13 HTT 3609/4885BCL3 1/4885POLB 1339/4885
US-20170267653-A1 BCL-3 INHIBITORS BCL3, BCL2, BCL2L13 HTT 3609/4885BCL3 1/4885POLB 1339/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.